GW786034

What GW786034 Means in Everyday Medical Language

GW786034 is another name for pazopanib hydrochloride, a cancer drug also sold under the brand name Votrient. It is a targeted therapy designed to slow or stop the growth of certain cancers by blocking proteins that tumors need to grow new blood vessels. Tumors rely on these new blood vessels to get oxygen and nutrients, so stopping this process can limit tumor growth.

Why GW786034 Can Matter in Cancer Care

Pazopanib hydrochloride is used mainly for adults with advanced renal cell carcinoma, a common type of kidney cancer, and advanced soft tissue sarcoma, which affects muscles, fat, and other connective tissues. It is usually given after other treatments have been tried. By targeting specific proteins called tyrosine kinases, it acts as an antiangiogenesis agent, meaning it blocks the formation of new blood vessels that tumors need to survive and grow. This can help control cancer progression when other options are limited.

What Patients Might See or Hear About GW786034

Patients may hear their doctor mention pazopanib, Votrient, or GW786034. These all refer to the same drug. It is usually taken as a pill and may be part of a treatment plan when other therapies have not worked or are not suitable. Patients might also find information about this drug on clinical trial listings or cancer information websites. Doctors will discuss possible side effects and the importance of monitoring during treatment.

Where GW786034 Might Appear

The term GW786034 can show up in medical records, treatment plans, lab reports, or clinical trial descriptions. It may also appear on drug information pages or patient education materials. Because it has several names, comparing the wording in reports or sources can help avoid confusion.

What GW786034 Does Not Automatically Mean

Seeing the name GW786034 or pazopanib does not mean the cancer will shrink or disappear. This drug is not a cure but a treatment that may help slow cancer growth. It also does not work for all types of cancer or all patients. Side effects related to blood pressure, wound healing, or bleeding risks can occur because of how the drug works.

Common Questions Patients Could Ask Their Care Team

Patients might ask how pazopanib works, what side effects to watch for, how doctors will know if it is working, and whether it can be taken with other medications. Understanding these points can help patients feel more informed and involved in their care.

How to Read the Term in Context

It is important to consider the type of cancer, treatment history, and doctor’s recommendations when seeing the term GW786034 or pazopanib. This helps avoid misunderstandings about what the drug can do and what to expect from treatment.

Safety and Next Steps

This information is meant to educate and support patients and caregivers but does not replace medical advice. Each person’s situation is unique. If you see GW786034 or pazopanib mentioned in your medical records or discussions, the best next step is to ask your healthcare team what it means for your specific care and treatment plan.